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Abstract. Two patients with cervical paragangliomas 
underwent positron emission tomography (PET) with 2- 
[18F]-fluoro-2-deoxy-D-glucose (FDG). There was 
marked tumor uptake and retention of FDG. Adjacent 
salivary gland accumulation of FDG was minimal, 
though quite prominent with meta-iodobenzylguanidine. 
FDG PET offers another potentially useful approach to 
functional imaging of these uncommon tumors, indepen- 
dent of the presence of specific amine uptake mecha- 
nisms or cell surface receptors required by other scinti- 
graphic techniques. 
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Introduct ion 
Cervical paragangliomas are uncommon neoplasms de- 
rived from neural crest cells, and are also referred to as 
chemodectomas,  carotid body tumors, glomus vagale tu- 
mors, or glomus tympanicum tumors, depending upon 
their structure of origin. Bilaterality and association with 
paragangliomas elsewhere are more common in the set- 
ting of familial and endocrine neoplasia syndromes [1]. 
Distant metastases (12% of carotid body tumors) and 
catecholamine synthesis (1% of paragangliomas) are 
rare [1, 2]. The usual history of these tumors is of  relent- 
less local growth, eventually producing symptoms by 
mass effect and progressive compromise of local neuro- 
vascular structures [3]. Anatomic imaging techniques re- 
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ly upon characteristic spatial relations and high vascular- 
ity of  the tumors, while modern scintigraphy exploits 
their neuroendocrine heritage with meta-iodobenzyl- 
guanidine (MIBG) and somatostatin receptor agonists. 
We describe the metabolic imaging of these tumors with 
positron emission tomography (PET) and 2-[18F]-fluoro - 
2-deoxy-D-glucose (FDG), and explore the potential use- 
fulness of this technique in comparison with MIBG sin- 
gle-photon emission tomography (SPET). 
Materials and methods  
PET images (12 min transmission, 15 min emission) of the neck 
were obtained beginning -50 rain following intravenous injection 
of 370 MBq (10 mCi) FDG using a Siemens Exact whole-body 
PET scanner. The data were reconstructed into cross-sectional im- 
ages with a Hann filter and a cutoff frequency of 0.3. Whole-body 
images from the top of the skull to the proximal lower extremities 
were acquired by the method of Dahlbom [4]. SPET images of the 
neck were obtained 48 h after intravenous injection of 18.5 MBq 
(0.5 mCi) of iodine-13t MIBG for 30 min (patient 1) or 24 h after 
intravenous injection of 370 MBq (10 mCi) iodine-123 MIBG for 
15 min (patient 2) using a Picker Prism triple-headed gamma cam- 
era rotated through 120 stops. Data were reconstructed into cross- 
sectional images by filtered back projection, a Butterworth filter 
and a cutoff of 0.2-0.5. Planar spot images were acquired from 
the top of the skull to the proximal lower extremities for 20 min 
each at 48 h (patient 1, I;JI-MIBG) and 10 min each at 24 h (pa- 
tient 2, J23I-MIBG) using a dual-head gamma camera with high- 
energy and low-energy collimators respectively. 
Results  
Patient 1 
A 61-year-old woman with a history of mild asthma and 
gastroesophageal reflux presented with a firm left neck 
mass of  - 2  cm diameter which had not resolved despite 
multiple courses of antibiotics. Panendoscopy of the up- 
per aerodigestive tract was unremarkable. Exploration of 
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the left neck revealed a number of small lymph nodes lo- 
cated over the internal jugular vein, biopsies of which 
yielded only normal lymphoid tissue. However, a 3 cm 
by 3 cm, fleshy, violaceous mass was visible immediate- 
ly deep to the nodes, splaying the internal and external 
carotid arteries at their origin. A provisional diagnosis of  
a carotid body tumor was made and the incision closed. 
Subsequent urinary catecholamine and metabolite levels 
were normal. 
FDG PET, ~3q-MIBG planar and SPET, MRI, and ca- 
rotid angiography studies were performed (Fig. 1). PET 
images showed intense accumulation of FDG within the 
tumor (Fig. 1A, D, G). The standardized uptake value 
(SUV) was 7.7[5]. Salivary gland activity was minimal. 
Fig. 1 A-I. Representative images from patient 1. Transverse (top 
row), coronal (center row), and sagittal sections (bottom row) 
from FDG-PET (A , D, G), 131I-MIBG SPET (B, E, H), MRI (C, 
F), and carotid angiography studies (I). There is intense uptake of 
FDG and MIBG within the left neck mass. Normal left parotid 
salivary gland activity seen on 13~I-MIBG images is masked by tu- 
mor uptake in transverse section B, but evident superior to tumor 
uptake in coronal section E and sagittal section H. Tl-weighted 
MR images after (C, axial) and before (F, coronal) administration 
of gadolinium demonstrate the left-sided soft tissue mass with in- 
homogeneous enhancement following gadolinium injection. Angi- 
ography (I) shows a mass with a vascular blush splaying the carot- 
id bifurcation, characteristic of a carotid body tumor 
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MIBG SPET images demonstrated intense tracer uptake 
in the tumor adjacent to the normal left parotid activity 
(Fig. 1B , E , H). For comparison, the MRI and angio- 
graphic studies are also shown in Fig. 1. There was a 
single lesion within the carotid bifurcation isointense to 
adjacent soft tissue on precontrast Tl-weighted images, 
with intense heterogeneous "salt and pepper" appearance 
following gadolinium contrast enhancement (Fig. 1C, F, 
I)[6]. Whole-body images from both the FDG and 
MIBG studies were otherwise unremarkable, and 
showed no evidence of tumors elsewhere. 
The resection was uneventful and histologic examina- 
tion was consistent with a carotid body tumor. 
Patient 2 
A 41-year-old otherwise healthy woman presented to her 
local otolaryngologist describing persistent rhinorrhea, 
nasal congestion and more recent development of pain- 
less right neck swelling. Findings on physical examina- 
tion were mild right anterior cervical adenopathy, a 3x4 
cm mass posterior to the angle of the right mandible, 
sluggish movements of the right vocal cord and marked 
medial displacement of the right palate. Profuse hemor- 
rhage complicated biopsy of the right neck prominence, 
which was reported as consistent with a "glomus tu- 
mor". 
The patient was referred to this institution for further 
investigation. Carotid angiography revealed a vascular 
Fig. 2 A-D. Images from patient 2. Transverse (A) and anterior 
projection (C) images from FDG PET demonstrate an abnormal 
focus of FDG accumulation in the right neck. The corresponding 
~2~I-MIBG transverse section is presented in B. Note that the tu- 
mor, readily visible on SPET, is not apparent on a standard anteri- 
or planar view (D) 
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lesion at the carotid bifurcation splaying the proximal 
internal and external carotid arteries, with a characteris- 
tic intense vascular blush. An oxygen-15 water quantita- 
tive cerebral perfusion study revealed no adverse reduc- 
tion in perfusion, electroencephalographic changes, or 
neurologic dysfunction upon occlusion of the right inter- 
nal carotid artery. FDG PET images showed intense up- 
take of tracer by the lesion (Fig. 2A,  C). The SUV was 
5.6. MIBG SPET images showed distinct accumulation 
within the tumor, medial to the right parotid activity 
(Fig. 2 B), while planar view showed only subtle asym- 
metry adjacent to the parotid glands (Fig. 2 D). There 
was no abnormal uptake elsewhere in the body on either 
the FDG or MIBG studies to suggest additional neuroen- 
docrine tumors. Plasma and urine catecholamines and 
metabolites were normal. 
The feeding vessels were embolized and the tumor 
subsequently resected. This required a mandibulotomy, 
together with partial resection of the right external carot- 
id artery, internal jugular vein, the vagus, hypoglossal, 
spinal accessory and lingual nerves, and the right cervi- 
cal sympathetic chain. Histology showed a glomus tu- 
mor. After additional revision procedures and renerva- 
tion of the right vocal cord the patient has satisfactory 
laryngeal function and cosmetic result. 
Discussion 
The typical location and hypervascularity of carotid 
body tumors has been described by dynamic computed 
tomography and contrast angiography studies [7]. Mag- 
netic resonance imaging shows focal low signal regions 
within the tumor on Tl-weighted pre-contrast images, a 
heterogeneous "salt and pepper" appearance on T2- 
weighted images, and intense enhancement following 
administration of gadolinium [6]. 
Scintigraphy of these tumors initially comprised sim- 
ple radionuclide angiography, used in one series to 
screen kindred members in familial paraganglionoma [1, 
8]. The neural crest origin of the tumors, and the pres- 
ence of biogenic amine uptake-1 and intracellular stor- 
age, was later exploited using MIBG. The low incidence 
of carotid body tumors has been a factor in the limited 
reported experience with this agent in carotid body tu- 
mors. Van Gils et al. demonstrated tumor uptake of 123I- 
MIBG in 8 of 15 patients with known chemodectomas 
[2]. The sensitivity with 131I-MIBG appears slightly low- 
er, with uptake described in known lesions in four of ten 
patients [9]. The normal marked salivary gland uptake of 
MIBG may mask the presence of an adjacent tumor and, 
thus, SPET should be performed whenever possible [10]. 
Neuroendocrine tissues frequently express somatosta- 
tin receptors. As part of a study of paragangliomas with 
indium-111 pentetreotide, Kwekkeboom et al. reported 
successful detection of tumor in 13 of 14 patients with 
known carotid body tumors [11]. Among 25 patients 
with paragangliomas, unsuspected additional tumor sites 
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were identified in nine. The ability to study the whole 
body in a single examination is an advantage in a condi- 
tion where multiple lesions may be present. Our patients 
were studied prior to commercial availability of this 
agent. 
The substantial elevation of glucose uptake and reten- 
tion by tumors relative to most non-neoplastic tissue is 
fundamental to FDG PET imaging in oncology [12]. 
This approach has been successful in visualizing neuro- 
endocrine tumors even when the specific cellular mecha- 
nisms necessary for imaging with MIBG are absent [13]. 
PET with FDG clearly demonstrated the known tumors 
in these two patients. These tumors, though benign, were 
quite metabolically active. Salivary gland uptake of FDG 
was very low compared to that of MIBG, an advantage 
given the characteristic location of these tumors. This 
preliminary report suggests that FDG PET may be a use- 
ful adjunct in the detection and staging of cervical para- 
gangliomas. 
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